FDA Inspection
BSP Pharmaceuticals SpABSP Pharmaceuticals SpA – FDA Inspection, Sep 21, 2018
Record Details
This FDA Inspection record concerns BSP Pharmaceuticals SpA, with an inspection on September 21, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Ephrem T. Hunde (Issuing Officer)
- Jessica Hankins (Issuing Officer)
- Reyes Candau-Chacon (Issuing Officer)
View Company Profile
ID · bf14bd98-e87e-47fb-b46f-59c1a4683aeb
Inspection Facts
- Inspection number
- 1071722
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of BSP Pharmaceuticals SpA
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 29, 2024 | Not classified | Office of Inspections and Investigations | |
| November 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BSP Pharmaceuticals SpA
- FDA Inspection 1232171 - 2024-02-29
- FDA Inspection 1172555 - 2021-11-12
- FDA Inspection 1091112 - 2017-10-20
- FDA Inspection 1016102 - 2016-12-16
- FDA Inspection 935609 - 2015-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.